VESTAL, N.Y. — The Binghamton University School of Pharmacy and Pharmaceutical Sciences has signed an articulation agreement with Ithaca College.
The pact will allow students to transfer into Binghamton’s doctor of pharmacy (PharmD) program after three years of undergraduate study, Binghamton announced.
It is a 3+4 program that will allow qualified Ithaca College students to complete their bachelor’s degree through coursework taken in their first professional year at Binghamton.
(Sponsored)
Don’t Take the Bait: Phishing Scams to Avoid
Americans lost $8.8 billion to phishing and other fraud in 2022, according to the Federal Trade Commission, with financial fraud increasing over 30% from 2021. Every day, thousands of people
New Sexual Harassment Policy and Training Requirements. Does Your Policy Comply?
New York State requires all employers to provide annual sexual harassment prevention training and a harassment policy to its employees. This requirement applies to all employees, including hourly and salaried,
“This agreement solidifies the mutual commitment Binghamton University has with Ithaca College to support the preparation of outstanding pharmacy professionals who will focus on patient-centered care,” Gloria Meredith, founding dean of the School of Pharmacy and Pharmaceutical Sciences, said in a statement. “As we expand our reach throughout New York state, it is gratifying to have developed these strong connections and we look forward to enrolling highly qualified students from Ithaca College.”
Students must have successfully completed the prerequisite credits from Ithaca College and apply no later than Jan. 1 of the year they plan to enroll at Binghamton. They must also carry a minimum cumulative and math/science grade point average of 3.0.
The school will waive the Pharmacy College Admissions Test (PCAT) for students who meet those qualifications.
Candidates in good standing will have the option of spending their fourth year at Ithaca College to complete their bachelor’s degree, rather than at Binghamton University in the first year of the PharmD program. This option will necessarily extend the length of the program to eight years, rather than the seven years of the 3+4 program, Binghamton said.
“We believe this program will benefit both campuses by attracting academically promising students, ultimately yielding well-prepared professionals for the field,” Linda Petrosino, dean of IC’s School of Health Sciences and Human Performance, said.
Binghamton’s School of Pharmacy also has 3+4 agreements with Cornell University College of Agriculture and Life Sciences and Wells College, along with 2+4 programs with SUNY Broome Community College, Onondaga Community College, and SUNY Nassau Community College, per the news release.
Contact Reinhardt at ereinhardt@cnybj.com
